- Report
- March 2022
- 146 Pages
Global
From €5292EUR$6,000USD£4,649GBP
€6616EUR$7,500USD£5,812GBP
- Drug Pipelines
- March 2022
- 73 Pages
Global
From €2787EUR$3,160USD£2,449GBP
€3484EUR$3,950USD£3,061GBP
- Report
- July 2024
- 105 Pages
Global
From €4190EUR$4,750USD£3,681GBP
- Report
- April 2023
- 120 Pages
Global
From €4190EUR$4,750USD£3,681GBP
- Report
- April 2023
- 110 Pages
Global
From €4190EUR$4,750USD£3,681GBP
- Report
- October 2024
- 136 Pages
North America
From €3528EUR$4,000USD£3,100GBP
- Report
- February 2024
- 185 Pages
Global
From €3969EUR$4,500USD£3,487GBP
- Report
- October 2023
- 84 Pages
Canada
From €3087EUR$3,500USD£2,712GBP
- Report
- October 2023
- 89 Pages
Egypt
From €3087EUR$3,500USD£2,712GBP
- Report
- August 2023
- 74 Pages
Canada
From €3087EUR$3,500USD£2,712GBP
- Report
- August 2023
- 75 Pages
Israel
From €3087EUR$3,500USD£2,712GBP
- Report
- May 2024
- 137 Pages
Global
From €4873EUR$5,524USD£4,281GBP
€5733EUR$6,499USD£5,036GBP
- Report
- September 2024
- 184 Pages
Global
From €2205EUR$2,500USD£1,937GBP
- Report
- September 2022
- 120 Pages
Global
From €2205EUR$2,500USD£1,937GBP
- Report
- October 2025
- 150 Pages
Germany
From €3396EUR$3,850USD£2,983GBP
- Report
- September 2025
- 150 Pages
China
From €3396EUR$3,850USD£2,983GBP
- Report
- September 2025
- 150 Pages
Canada
From €3396EUR$3,850USD£2,983GBP
- Report
- April 2023
- 147 Pages
Global
From €4365EUR$4,949USD£3,835GBP
- Report
- July 2024
- 141 Pages
China
From €1588EUR$1,800USD£1,395GBP
- Report
- July 2024
- 268 Pages
China
From €3528EUR$4,000USD£3,100GBP

The Antihypertensive market is a subset of the Cardiovascular Drugs market, which focuses on medications used to treat high blood pressure. These drugs are used to reduce the risk of stroke, heart attack, and other cardiovascular diseases. Antihypertensives work by blocking the action of certain hormones, such as angiotensin II, which cause blood vessels to constrict. Common classes of antihypertensives include diuretics, beta blockers, ACE inhibitors, calcium channel blockers, and angiotensin receptor blockers.
The Antihypertensive market is highly competitive, with many large pharmaceutical companies offering a variety of products. Some of the major players in the market include Pfizer, Novartis, Merck, Sanofi, and GlaxoSmithKline. Other companies, such as AstraZeneca, Boehringer Ingelheim, and Daiichi Sankyo, also offer antihypertensive medications. Show Less Read more